Literature DB >> 18197997

Abnormalities in myocardial perfusion after surgical correction of pulmonary atresia with intact ventricular septum.

Britt-Marie Ekman-Joelsson1, Håkan Berggren, Ann-Britt Boll, Rune Sixt, Jan Sunnegårdh.   

Abstract

We describe the results of myocardial perfusion scintigraphy performed 4 to 15 years after surgery in 12 patients with pulmonary atresia and intact ventricular septum. We used single photon emission computed tomography after injection of technetium Tc-99m tetrofosmin at submaximal exercise test. The patients, 7 girls and 5 boys, with a mean age of 11 years, and a range from 6 to 19 years, had either undergone biventricular repair, in 5 cases, or univentricular palliation in the remaining 7. This second group included 4 patients with ventriculo-coronary arterial communications. Of the children, 3 with biventricular repair and 6 with univentricular palliation had perfusion defects. Children with biventricular repair had perfusion defects in the ventricular septum, while those having univentricular palliation also had defects located to the left ventricular free wall. All children with ventriculo-coronary arterial communications had perfusion defects both in the ventricular septum and in the left ventricular free wall.

Entities:  

Mesh:

Year:  2008        PMID: 18197997     DOI: 10.1017/S1047951107001709

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Regression of a coronary arterial fistula in an infant with pulmonary atresia and an intact ventricular septum.

Authors:  Anca Popoiu; Andreas Eicken; Thomas Genz; Christian Schreiber; John Hess
Journal:  Pediatr Cardiol       Date:  2009-10-27       Impact factor: 1.655

2.  Myocardial perfusion abnormalities in patients occurring more than 1 year after successful univentricular (Fontan surgery) and biventricular repair (complete repair of tetralogy of Fallot).

Authors:  A Priyadarshini; Anita Saxena; Chetan Patel; Vinod K Paul; Rakesh Lodha; Balram Airan
Journal:  Pediatr Cardiol       Date:  2012-10-12       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.